These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1859886)

  • 1. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.
    Neale GA; Menarguez J; Kitchingman GR; Fitzgerald TJ; Koehler M; Mirro J; Goorha RM
    Blood; 1991 Aug; 78(3):739-47. PubMed ID: 1859886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
    Dibenedetto SP; Lo Nigro L; Mayer SP; Rovera G; Schilirò G
    Blood; 1997 Aug; 90(3):1226-32. PubMed ID: 9242556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of T-cell receptor delta gene rearrangement by clonal specific polymerase chain reaction.
    Chan DW; Liang R; Chan V; Kwong YL; Chan TK
    Leukemia; 1997 Apr; 11 Suppl 3():281-4. PubMed ID: 9209365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
    Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
    Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
    Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
    Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of minimal residual disease in childhood acute lymphoblastic leukemia patients by polymerase chain reaction analysis of multiple clone-specific or malignancy-specific gene markers.
    Kuang S; Gu L; Dong S; Cao Q; Xu C; Huang W; Su XY; Huang QH; Xie JX; Chen SJ; Chen Z
    Cancer Genet Cytogenet; 1996 Jun; 88(2):110-7. PubMed ID: 8640718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCR-heteroduplex analysis of TCR gamma, delta and TAL-1 deletions in T-acute lymphoblastic leukemias: implications in the detection of minimal residual disease.
    Nirmala K; Rajalekshmy KR; Raman SG; Shanta V; Rajkumar T
    Leuk Res; 2002 Apr; 26(4):335-43. PubMed ID: 11839375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse.
    Biondi A; Yokota S; Hansen-Hagge TE; Rossi V; Giudici G; Maglia O; Basso G; Tell C; Masera G; Bartram CR
    Leukemia; 1992 Apr; 6(4):282-8. PubMed ID: 1316978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
    Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
    Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.
    Kitchingman GR
    Leukemia; 1994 Mar; 8(3):395-401. PubMed ID: 8127144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients.
    Yokota S; Hansen-Hagge TE; Ludwig WD; Reiter A; Raghavachar A; Kleihauer E; Bartram CR
    Blood; 1991 Jan; 77(2):331-9. PubMed ID: 1824678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia.
    Neale GA; Pui CH; Mahmoud HH; Mirro J; Crist WM; Rivera GK; Goorha RM
    Leukemia; 1994 May; 8(5):768-75. PubMed ID: 8182934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
    Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of minimal residual disease in leukemic patients with the t(10;14)(q24;q11) chromosomal translocation.
    Kagan J; Finger LR; Besa E; Croce CM
    Cancer Res; 1990 Sep; 50(17):5240-4. PubMed ID: 2386934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences.
    Hansen-Hagge TE; Yokota S; Bartram CR
    Blood; 1989 Oct; 74(5):1762-7. PubMed ID: 2676018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
    Nakao M; Janssen JW; Flohr T; Bartram CR
    Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia.
    Scholten C; Födinger M; Mitterbauer M; Laczika K; Mitterbauer G; Haas OA; Knöbl P; Schwarzinger I; Thalhammer R; Purtscher B
    Ann Hematol; 1995 Oct; 71(4):155-60. PubMed ID: 7578520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.